Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
Rensing, B J
Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. [electronic resource] - European heart journal Nov 2001 - 2125-30 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
0195-668X
10.1053/euhj.2001.2892 doi
Adult
Aged
Aged, 80 and over
Brazil--epidemiology
Coated Materials, Biocompatible--pharmacology
Cohort Studies
Coronary Angiography
Coronary Artery Disease--complications
Coronary Restenosis--etiology
Creatine Kinase--blood
Creatine Kinase, MB Form
Equipment Safety
Europe--epidemiology
Female
Follow-Up Studies
Humans
Immunosuppressive Agents--pharmacology
Isoenzymes--blood
Male
Middle Aged
Prosthesis Implantation--instrumentation
Sirolimus--pharmacology
Stents
Ultrasonography, Interventional
Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. [electronic resource] - European heart journal Nov 2001 - 2125-30 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
0195-668X
10.1053/euhj.2001.2892 doi
Adult
Aged
Aged, 80 and over
Brazil--epidemiology
Coated Materials, Biocompatible--pharmacology
Cohort Studies
Coronary Angiography
Coronary Artery Disease--complications
Coronary Restenosis--etiology
Creatine Kinase--blood
Creatine Kinase, MB Form
Equipment Safety
Europe--epidemiology
Female
Follow-Up Studies
Humans
Immunosuppressive Agents--pharmacology
Isoenzymes--blood
Male
Middle Aged
Prosthesis Implantation--instrumentation
Sirolimus--pharmacology
Stents
Ultrasonography, Interventional